Processa Pharmaceuticals, Inc. Repayments of Debt
Processa Pharmaceuticals, Inc. (PCSA) reported Repayments of Debt of $19.90 thousand for the 12-month period ending 2015-12-31, per its 10-K filed 2017-09-25.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfDebt · last filed 2017-09-25
- Processa Pharmaceuticals, Inc. repayments of debt for the quarter ending 2015-12-31 was $0.00, a 100.00% decline year-over-year.
- Processa Pharmaceuticals, Inc. repayments of debt for the quarter ending 2015-09-30 was -$8.13K, a 162.63% decline year-over-year.
- Processa Pharmaceuticals, Inc. repayments of debt for the quarter ending 2015-06-30 was $14.07K, a 70.98% increase year-over-year.
- Processa Pharmaceuticals, Inc. repayments of debt for the quarter ending 2015-03-31 was $13.96K, a 33.54% increase year-over-year.
- Processa Pharmaceuticals, Inc. repayments of debt for fiscal 2015 was $19.90K, a 56.29% decline from fiscal 2014.
- Processa Pharmaceuticals, Inc. repayments of debt for fiscal 2014 was $45.53K, a 50.56% increase from fiscal 2013.
- Processa Pharmaceuticals, Inc. repayments of debt for fiscal 2013 was $30.24K, a 239.23% increase from fiscal 2012.
- Processa Pharmaceuticals, Inc. repayments of debt for fiscal 2012 was $8.91K.
| Period end | Repayments of Debt 3 month | Repayments of Debt 6 month | Repayments of Debt 9 month | Repayments of Debt 12 month | Repayments of Debt 27 month | Repayments of Debt 30 month | Repayments of Debt 33 month | Repayments of Debt 36 month |
|---|---|---|---|---|---|---|---|---|
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-25 | -$8.13K derived: sum of 2 quarters · filed 2017-09-25 | $5.94K derived: sum of 3 quarters · filed 2017-09-25 | $19.90K 10-K · filed 2017-09-25 | ||||
| 2015-09-30 | -$8.13K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-09-08 | $5.94K derived: sum of 2 quarters · filed 2017-09-08 | $19.90K 10-Q · filed 2017-09-08 | $33.76K derived: sum of 4 quarters · filed 2017-09-08 | ||||
| 2015-06-30 | $14.07K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-30 | $28.03K 10-Q · filed 2017-08-30 | $41.89K derived: sum of 3 quarters · filed 2017-08-30 | $54.88K derived: sum of 4 quarters · filed 2017-08-30 | ||||
| 2015-03-31 | $13.96K 10-Q · filed 2017-08-07 | $27.82K derived: sum of 2 quarters · filed 2017-08-07 | $40.81K derived: sum of 3 quarters · filed 2017-08-07 | $49.03K derived: sum of 4 quarters · filed 2017-08-07 | ||||
| 2014-12-31 | $13.86K derived: 10-K 12 month − 10-Q 9 month · filed 2017-06-19 | $26.84K derived: sum of 2 quarters · filed 2017-06-19 | $35.07K derived: sum of 3 quarters · filed 2017-06-19 | $45.53K 10-K · filed 2017-06-19 | ||||
| 2014-09-30 | $12.98K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-12-01 | $21.21K derived: sum of 2 quarters · filed 2015-12-01 | $31.67K 10-Q · filed 2015-12-01 | $41.56K derived: sum of 4 quarters · filed 2015-12-01 | ||||
| 2014-06-30 | $8.23K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-19 | $18.68K 10-Q · filed 2015-08-19 | $28.58K derived: sum of 3 quarters · filed 2015-08-19 | $35.41K derived: sum of 4 quarters · filed 2015-08-19 | ||||
| 2014-03-31 | $10.46K 10-Q · filed 2015-05-15 | $20.35K derived: sum of 2 quarters · filed 2015-05-15 | $27.18K derived: sum of 3 quarters · filed 2015-05-15 | $33.96K derived: sum of 4 quarters · filed 2015-05-15 | $49.61K 10-Q · filed 2014-05-14 | |||
| 2013-12-31 | $9.89K derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-14 | $16.72K derived: sum of 2 quarters · filed 2015-04-14 | $23.50K derived: sum of 3 quarters · filed 2015-04-14 | $30.24K 10-K · filed 2015-04-14 | $39.15K 10-K · filed 2014-03-27 | |||
| 2013-09-30 | $6.83K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $13.61K derived: sum of 2 quarters · filed 2014-11-13 | $20.35K 10-Q · filed 2014-11-13 | $29.26K 10-Q · filed 2013-11-08 | ||||
| 2013-06-30 | $6.78K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-19 | $13.52K 10-Q · filed 2014-08-19 | $22.43K 10-Q/A · filed 2013-09-06 | |||||
| 2013-03-31 | $6.74K 10-Q · filed 2014-05-14 | |||||||
| 2012-12-31 | $8.91K 10-K · filed 2014-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |